<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39408710</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10379</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251910379</ELocationID><Abstract><AbstractText>During the COVID-19 pandemic, diabetic and obese patients experienced higher rates of hospital admissions, severe illness, and mortality. However, vaccinations failed to provide those vulnerable populations the same level of protection against COVID-19 severity as those without diabetic and obese phenotypes. Our study aimed to investigate how diabetes mellitus (DM) impacts the immune response following vaccination including the artificially designed trimeric SARS-CoV-2 spike (S)-protein. By using two diabetic mouse models, ob/ob mice (obese, hyperglycemic, and insulin-resistant) and STZ-treated mice (insulin-deficient and hyperglycemic), we observed a significant reduction in S-protein-specific IgG antibody titer post-vaccination in both diabetic models compared to wild-type (WT) mice. Both diabetic mouse models exhibited significant abnormalities in spleen tissue, including marked reductions in splenic weight and the size of the white pulp regions. Furthermore, the splenic T-cell and B-cell zones were notably diminished, suggesting an underlying immune dysfunction that could contribute to impaired antibody production. Notably, vaccination with the S-protein, when paired with an optimal adjuvant, did not exacerbate diabetic cardiomyopathy, blood glucose levels, or liver function, providing reassurance about the vaccine's safety. These findings offer valuable insights into potential mechanisms responsible for the decreased persistence of antibody production in diabetic patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atef</LastName><ForeName>Yara</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1232-7268</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Tomoya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1858-6009</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuda</LastName><ForeName>Akitsu</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9402-924X</Identifier><AffiliationInfo><Affiliation>Laboratory of Creative Science for Insect Industries, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 819-0395, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9426-911X</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Akiyuki</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2309-3994</Identifier><AffiliationInfo><Affiliation>National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, School of Life Science, The Graduate University for Advanced Studies (SOKENDAI), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanda</LastName><ForeName>Yasunari</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2527-3526</Identifier><AffiliationInfo><Affiliation>Division of Pharmacology, National Institute of Health Sciences, Kawasaki 210-9501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunisawa</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Vaccine Materials, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusakabe</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Insect Genome Science, Kyushu University Graduate School of Bioresource and Bioenvironmental Sciences, Fukuoka 819-0395, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishida</LastName><ForeName>Motohiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, School of Life Science, The Graduate University for Advanced Studies (SOKENDAI), Okazaki 444-8787, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JPMJCR2024 (20348438)</GrantID><Agency>Japan Science and Technology Agency</Agency><Country /></Grant><Grant><GrantID>22K19395</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>23K06164</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>21H05269</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>21H05258</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>JP223fa827001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country /></Grant><Grant><GrantID>JP223fa727001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="Y">Spleen</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003921" MajorTopicYN="Y">Diabetes Mellitus, Experimental</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008820" MajorTopicYN="N">Mice, Obese</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">S-protein</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adjuvant optimization</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">spleen</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408710</ArticleId><ArticleId IdType="pmc">PMC11476529</ArticleId><ArticleId IdType="doi">10.3390/ijms251910379</ArticleId><ArticleId IdType="pii">ijms251910379</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stierman B., Afful J., Carroll M.D., Chen T.C., Davy O., Fink S., Fryar C.D., Gu Q., Hales C.M., Hughes J.P., et al. National Health Statistics Reports. The Centers for Disease Control and Prevention (CDC); Atlanta, Georgia: 2021. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/CDC:106273</ArticleId><ArticleId IdType="pubmed">39380201</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson-Stuttard J., Blundell S., Harris T., Cook D.G., Critchley J. Diabetes and Infection: Assessing the Association with Glycaemic Control in Population-Based Studies. Lancet Diabetes Endocrinol. 2016;4:148–158. doi: 10.1016/S2213-8587(15)00379-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00379-4</ArticleId><ArticleId IdType="pubmed">26656292</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao P., Song Y., Zhuang Z., Ran J., Xu L., Geng Y., Han L., Zhao S., Qin J., He D., et al. Obesity and COVID-19 in Adult Patients with Diabetes. Diabetes. 2021;70:1061–1069. doi: 10.2337/db20-0671.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db20-0671</ArticleId><ArticleId IdType="pubmed">33597204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregg E.W., Sophiea M.K., Weldegiorgis M. Diabetes and COVID-19: Population Impact 18 Months into the Pandemic. Diabetes Care. 2021;44:1916–1923. doi: 10.2337/dci21-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci21-0001</ArticleId><ArticleId IdType="pubmed">34244333</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Ning Z., Chen Y., Guo M., Liu Y., Gali K., Sun L., Duan Y., Cai J., Westerdahl D., et al. Aerodynamic Analysis of SARS-CoV-2 in Two Wuhan Hospitals. Nature. 2020;582:557–560. doi: 10.1038/s41586-020-2271-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2271-3</ArticleId><ArticleId IdType="pubmed">32340022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulut C., Kato Y. Epidemiology of COVID-19. Turk. J. Med. Sci. 2020;50:563–570. doi: 10.3906/sag-2004-172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2004-172</ArticleId><ArticleId IdType="pmc">PMC7195982</ArticleId><ArticleId IdType="pubmed">32299206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E., Ritchie H., Ortiz-Ospina E., Roser M., Hasell J., Appel C., Giattino C., Rodés-Guirao L. A global database of COVID-19 vaccinations. Nat. Hum. Behav. Vol. 2020;5:947–953. doi: 10.1038/s41562-021-01122-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01122-8</ArticleId><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani K., Shavaleh R., Forouhi M., Disfani H.F., Kamandi M., Oskooi R.K., Foogerdi M., Soltani M., Rahchamani M., Mohaddespour M., et al. The Effectiveness of COVID-19 Vaccines in Reducing the Incidence, Hospitalization, and Mortality from COVID-19: A Systematic Review and Meta-Analysis. Front. Public Health. 2022;10:873596. doi: 10.3389/fpubh.2022.873596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.873596</ArticleId><ArticleId IdType="pmc">PMC9459165</ArticleId><ArticleId IdType="pubmed">36091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Soetedjo N.N.M., Iryaningrum M.R., Lawrensia S., Permana H. Antibody Response Following SARS-CoV-2 Vaccination among Patients with Type 2 Diabetes Mellitus: A Systematic Review. Diabetes Metab. Syndr. Clin. Res. Rev. 2022;16:102406. doi: 10.1016/j.dsx.2022.102406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102406</ArticleId><ArticleId IdType="pmc">PMC8776339</ArticleId><ArticleId IdType="pubmed">35104750</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R., Sardu C., Prattichizzo F., Scisciola L., Messina V., La Grotta R., Luisa Balestrieri M., Maggi P., Napoli C., Ceriello A., et al. Glycaemic Control Is Associated with SARS-CoV-2 Breakthrough Infections in Vaccinated Patients with Type 2 Diabetes. Nat. Commun. 2022;13:2318. doi: 10.1038/s41467-022-30068-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30068-2</ArticleId><ArticleId IdType="pmc">PMC9051134</ArticleId><ArticleId IdType="pubmed">35484164</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Balena A., Tuccinardi D., Tozzi R., Risi R., Masi D., Caputi A., Rossetti R., Spoltore M.E., Filippi V., et al. Central Obesity, Smoking Habit, and Hypertension Are Associated with Lower Antibody Titres in Response to COVID-19 MRNA Vaccine. Diabetes Metab. Res. Rev. 2022;38:e3465. doi: 10.1002/dmrr.3465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3465</ArticleId><ArticleId IdType="pmc">PMC8209952</ArticleId><ArticleId IdType="pubmed">33955644</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Klaauw A.A., Horner E.C., Pereyra-Gerber P., Agrawal U., Foster W.S., Spencer S., Vergese B., Smith M., Henning E., Ramsay I.D., et al. Accelerated Waning of the Humoral Response to COVID-19 Vaccines in Obesity. Nat. Med. 2023;29:1146–1154. doi: 10.1038/s41591-023-02343-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02343-2</ArticleId><ArticleId IdType="pmc">PMC10202802</ArticleId><ArticleId IdType="pubmed">37169862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhamar G., Briganti S., Maggi D., Viola V., Faraj M., Zannella C., Galdiero M., Franci G., Fusco C., Isgrò C., et al. Prevaccination Glucose Time in Range Correlates with Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes. J. Clin. Endocrinol. Metab. 2023;108:e474–e479. doi: 10.1210/clinem/dgad001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad001</ArticleId><ArticleId IdType="pmc">PMC10807908</ArticleId><ArticleId IdType="pubmed">36611249</ArticleId></ArticleIdList></Reference><Reference><Citation>D’addio F., Sabiu G., Usuelli V., Assi E., Abdelsalam A., Maestroni A., Seelam A.J., Nasr M.B., Loretelli C., Mileto D., et al. Immunogenicity and Safety of SARS-CoV-2 MRNA Vaccines in a Cohort of Patients with Type 1 Diabetes. Diabetes. 2022;71:1800–1806. doi: 10.2337/db22-0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db22-0053</ArticleId><ArticleId IdType="pubmed">35551366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z., Zhu H., Wang X., Jing B., Li Z., Xia X., Sun H., Yang Y., Zhang W., Shi L., et al. Adjuvants for Coronavirus Vaccines. Front. Immunol. 2020;11:589833. doi: 10.3389/fimmu.2020.589833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589833</ArticleId><ArticleId IdType="pmc">PMC7677582</ArticleId><ArticleId IdType="pubmed">33240278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Channappanavar R., Ma C., Wang L., Tang J., Garron T., Tao X., Tasneem S., Lu L., Tseng C.T.K., et al. Identification of an Ideal Adjuvant for Receptor-Binding Domain-Based Subunit Vaccines against Middle East Respiratory Syndrome Coronavirus. Cell. Mol. Immunol. 2016;13:180–190. doi: 10.1038/cmi.2015.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2015.03</ArticleId><ArticleId IdType="pmc">PMC4786625</ArticleId><ArticleId IdType="pubmed">25640653</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Alameh M.-G., Butowska K., Knox J.J., Lundgreen K., Ghattas M., Gong N., Xue L., Xu Y., Lavertu M., et al. Nature Nanotechnology Adjuvant Lipidoid-Substituted Lipid Nanoparticles Augment the Immunogenicity of SARS-CoV-2 MRNA Vaccines. Nat. Nanotechnol. 2023;18:1105–1114. doi: 10.1038/s41565-023-01404-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-023-01404-4</ArticleId><ArticleId IdType="pubmed">37365276</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuy C., Le T., Ahn S.Y., Ho T.L., Lee J., Lee D.-H., Hwang H.S., Kang S.-M., Ko E.-J. Adjuvant Effects of Combination Monophosphoryl Lipid A and Poly I:C on Antigen-Specific Immune Responses and Protective Efficacy of Influenza Vaccines. Sci. Rep. 2023;13:12231. doi: 10.1038/s41598-023-39210-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39210-6</ArticleId><ArticleId IdType="pmc">PMC10382554</ArticleId><ArticleId IdType="pubmed">37507413</ArticleId></ArticleIdList></Reference><Reference><Citation>Suriano F., Vieira-Silva S., Falony G., Roumain M., Paquot A., Pelicaen R., Régnier M., Delzenne N.M., Raes J., Muccioli G.G., et al. Novel Insights into the Genetically Obese (Ob/Ob) and Diabetic (Db/Db) Mice: Two Sides of the Same Coin. Microbiome. 2021;9:147. doi: 10.1186/s40168-021-01097-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-021-01097-8</ArticleId><ArticleId IdType="pmc">PMC8240277</ArticleId><ArticleId IdType="pubmed">34183063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Y., Ariyoshi K., Nohara Y., Matsunaga N., Shimauchi T., Shindo N., Nishimura A., Mi X., Kim S.G., Ide T., et al. Inhibition of Dynamin-Related Protein 1-Filamin Interaction Improves Systemic Glucose Metabolism. Br. J. Pharmacol. 2024. early view .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.16487</ArticleId><ArticleId IdType="pubmed">38986570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., Zidar D.A., Bristow M.R., Cameron S.J., Chan T., Harding C.V., Kwon D.H., Singh T., Tilton J.C., Tsai E.J., et al. COVID-19 and Cardiovascular Disease. Circ. Res. 2021;128:1214–1236. doi: 10.1161/CIRCRESAHA.121.317997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis with COVID-19 MRNA Vaccines. Circulation. 2021;144:471–484. doi: 10.1161/CIRCULATIONAHA.121.056135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugger H., Abel E.D. Rodent Models of Diabetic Cardiomyopathy. Dis. Model. Mech. 2009;2:454–466. doi: 10.1242/dmm.001941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.001941</ArticleId><ArticleId IdType="pubmed">19726805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis S.M., Williams A., Eisenbarth S.C. Structure and Function of the Immune System in the Spleen. Sci. Immunol. 2019;4:eaau6085. doi: 10.1126/sciimmunol.aau6085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aau6085</ArticleId><ArticleId IdType="pmc">PMC6495537</ArticleId><ArticleId IdType="pubmed">30824527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Ji Q., Liu Z., Tang K., Xie Y., Li K., Zhou J., Li S., Shang H., Shi Z., et al. Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant. Viruses. 2022;14:501. doi: 10.3390/v14030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030501</ArticleId><ArticleId IdType="pmc">PMC8950793</ArticleId><ArticleId IdType="pubmed">35336907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Mittal S., Aggarwal R., Chauhan M.K. Diabetes and Cardiovascular Disease: Inter-Relation of Risk Factors and Treatment. Future J. Pharm. Sci. 2020;6:130. doi: 10.1186/s43094-020-00151-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43094-020-00151-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Zhang Y., Witmer L., Chinchilli V.M., Ba D.M. Association of COVID-19 with Diabetes: A Systematic Review and Meta-Analysis. Sci. Rep. 2022;12:20191. doi: 10.1038/s41598-022-24185-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24185-7</ArticleId><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Lui D.T.W., Chung M.S.H., Au I.C.H., Lai F.T.T., Wan E.Y.F., Chui C.S.L., Li X., Cheng F.W.T., Cheung C.L., et al. Incidence of Diabetes Following COVID-19 Vaccination and SARS-CoV-2 Infection in Hong Kong: A Population-Based Cohort Study. PLoS Med. 2023;20:e1004274. doi: 10.1371/journal.pmed.1004274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004274</ArticleId><ArticleId IdType="pmc">PMC10406181</ArticleId><ArticleId IdType="pubmed">37486927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert E.R., Fu Z., Liu D. Development of a Nongenetic Mouse Model of Type 2 Diabetes. Exp. Diabetes Res. 2011;2011:416254. doi: 10.1155/2011/416254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/416254</ArticleId><ArticleId IdType="pmc">PMC3226533</ArticleId><ArticleId IdType="pubmed">22164157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahfoz A.M., Gawish A.Y. Insight into the Hepatoprotective, Hypolipidemic, and Antidiabetic Impacts of Aliskiren in Streptozotocin-Induced Diabetic Liver Disease in Mice. Diabetol. Metab. Syndr. 2022;14:163. doi: 10.1186/s13098-022-00935-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-022-00935-5</ArticleId><ArticleId IdType="pmc">PMC9620647</ArticleId><ArticleId IdType="pubmed">36316746</ArticleId></ArticleIdList></Reference><Reference><Citation>Rammohan R., Joy M., Saggar T., Magam S.G., Sinha A., Natt D., Mehta V., Bunting S., Anand P., Mustacchia P., et al. Investigating the Impact of COVID-19 Vaccines on Liver Function: Insights from a Single-Institute Study. Cureus. 2023;15:e36588. doi: 10.7759/cureus.36588.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36588</ArticleId><ArticleId IdType="pmc">PMC10035458</ArticleId><ArticleId IdType="pubmed">36968679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt S.L., Hodgkin P.D., Tarlinton D.M., Corcoran L.M. The Generation of Antibody-Secreting Plasma Cells. Nat. Rev. Immunol. 2015;15:160–171. doi: 10.1038/nri3795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3795</ArticleId><ArticleId IdType="pubmed">25698678</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller Y.D., Golshayan D., Ehirchiou D., Wyss J.C., Giovannoni L., Meier R., Serre-Beinier V., Yung G.P., Morel P., Bühler L.H., et al. Immunosuppressive Effects of Streptozotocin-Induced Diabetes Result in Absolute Lymphopenia and a Relative Increase of T Regulatory Cells. Diabetes. 2011;60:2331–2340. doi: 10.2337/db11-0159.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-0159</ArticleId><ArticleId IdType="pmc">PMC3161310</ArticleId><ArticleId IdType="pubmed">21752956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Qian J., Li B., Lu M., Le G., Xie Y. Metabolomics Based On1 H-Nmr Reveal the Regulatory Mechanisms of Dietary Methionine Restriction on Splenic Metabolic Dysfunction in Obese Mice. Foods. 2021;10:2439. doi: 10.3390/foods10102439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10102439</ArticleId><ArticleId IdType="pmc">PMC8535630</ArticleId><ArticleId IdType="pubmed">34681487</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh S.-J., Varkey P., Chen P.-Y., Chang S.-Y., Huang L.L.H. Counting CD4+ and CD8+ T Cells in the Spleen: A Novel In Vivo Method for Assessing Biomaterial Immunotoxicity. Regen. Biomater. 2014;1:11–16. doi: 10.1093/rb/rbu003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rb/rbu003</ArticleId><ArticleId IdType="pmc">PMC4669000</ArticleId><ArticleId IdType="pubmed">26816621</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X., Li J., Baldwin H.S. Postnatal Lethality and Abnormal Development of Foregut and Spleen in Ndrg4 Mutant Mice. Biochem. Biophys. Res. Commun. 2016;470:613–619. doi: 10.1016/j.bbrc.2016.01.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.01.096</ArticleId><ArticleId IdType="pmc">PMC4762668</ArticleId><ArticleId IdType="pubmed">26801554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Kim M.J., Lee I.K., Hong C.W., Jeon J.H. Diabetology International. Springer; Berlin/Heidelberg, Germany: 2024. Impact of Hyperglycemia on Immune Cell Function: A Comprehensive Review; pp. 1–16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S13340-024-00741-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerlings S.E., Hoepelman A.I.M. Immune Dysfunction in Patients with Diabetes Mellitus (DM) FEMS Immunol. Med. Microbiol. 1999;26:259–265. doi: 10.1111/j.1574-695X.1999.tb01397.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.1999.tb01397.x</ArticleId><ArticleId IdType="pubmed">10575137</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M., Cho E., Gliozheni E., Salem Y., Cheung J., Ichii H. Pathology of Diabetes-Induced Immune Dysfunction. Int. J. Mol. Sci. 2024;25:7105. doi: 10.3390/ijms25137105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25137105</ArticleId><ArticleId IdType="pmc">PMC11241249</ArticleId><ArticleId IdType="pubmed">39000211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafar N., Edriss H., Nugent K. The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am. J. Med. Sci. 2016;351:201–211. doi: 10.1016/j.amjms.2015.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2015.11.011</ArticleId><ArticleId IdType="pubmed">26897277</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda A., Lee J.M., Miyata T., Mon H., Sato K., Oyama K., Sakurai Y., Yasuda J., Takahashi D., Ueda T., et al. Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation with Alum Adjuvants. Front. Immunol. 2022;12:803647. doi: 10.3389/fimmu.2021.803647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.803647</ArticleId><ArticleId IdType="pmc">PMC8789674</ArticleId><ArticleId IdType="pubmed">35095889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>